Shopping Cart
Remove All
Your shopping cart is currently empty
Tuvonralimab (PSB-205) is a humanized monoclonal antibody targeting CTLA-4/CD152, often used in combination with Iparomlimab for cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $289 | - | In Stock | |
| 5 mg | $745 | - | In Stock | |
| 10 mg | $1,180 | - | In Stock | |
| 25 mg | $1,770 | - | In Stock | |
| 50 mg | $2,380 | - | In Stock |
| Description | Tuvonralimab (PSB-205) is a humanized monoclonal antibody targeting CTLA-4/CD152, often used in combination with Iparomlimab for cancer research. |
| Synonyms | QL1706 (iparomlimab/tuvonralimab), PSB-205, PBS105 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | PD-1/CTLA-4 |
| Molecular Weight | 144.99 kDa |
| Cas No. | 2417649-44-4 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.